Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition
Annamaria Rapisarda, Melinda Hollingshead, Badarch Uranchimeg, Carrie A. Bonomi, Suzanne D. Borgel, John P. Carter, Bradley Gehrs, Mark Raffeld, Robert J. Kinders, Ralph Parchment, Miriam R. Anver, Robert H. Shoemaker, and Giovanni Melillo